Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€48.17
18.12.20
€27.00
18.06.21
14.83%
19.01.21

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Snowman 
18.12.20 50%
buy
Humana Inc.

Start price
Target price
Perf. (%)
€364.00
03.11.20
-
04.11.21
-6.04%
14.01.21

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Higher risks for its business
NightTrain 
03.11.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€395.05
12.12.20
-
12.12.21
4.78%
09.01.21

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Traumtanz 
12.12.20 50%
buy
Agilent Technologies Inc.

Start price
Target price
Perf. (%)
€89.88
30.10.20
-
04.11.21
7.35%
03.01.21

Higher EBIT margin than peer group
Market Leader or Top 3
Known brand
Future proof or reliable business model
CandyButcher 
30.10.20 50%
buy
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€371.00
29.10.20
-
04.11.21
8.65%
30.12.20

EBIT growth >5% per year expected
Very low/no dividend yield expected
GraveDigger 
29.10.20 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€48.01
18.12.20
€45.00
-1.78%
23.12.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
18.12.20 50%
sell
Pfizer Inc.

Start price
Target price
Perf. (%)
€30.91
17.12.20
€29.00
-1.81%
21.12.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Traumtanz 
17.12.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€33.30
09.11.20
€37.95
-11.94%
17.12.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Traumtanz 
09.11.20 50%
sell
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€392.75
11.12.20
€250.00
0.97%
11.12.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Traumtanz 
11.12.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€450.00
-25.76%
11.12.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Traumtanz 
22.11.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.31
16.11.20
-
5.61%
11.12.20

FinanceClub_UoM 
16.11.20 50%
sell
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€437.60
19.11.20
€426.00
19.11.21
1.19%
23.11.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
geldnutzer 
19.11.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€51.30
14.11.20
-
14.11.21
-1.75%
23.11.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
14.11.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€453.60
01.09.17
€526.00
04.11.21
-3.53%
19.11.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
geldnutzer 
15.08.19 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€50.60
13.11.20
€52.00
1.38%
14.11.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
13.11.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€58.10
18.08.20
-
04.11.21
-12.10%
11.11.20

Could be worthwhile Investment >10% per year
Capable Management
Innovative
Market Leader or Top 3
Trip 
18.08.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€51.03
24.10.20
€58.00
04.11.21
-0.20%
11.11.20

Medium risks for its business
Risky Investment
phonebroker 
24.10.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€50.00
09.11.20
€55.00
2.66%
10.11.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
09.11.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€49.75
31.10.20
-
04.11.21
0.53%
09.11.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
31.10.20 50%
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€201.33
22.10.20
€216.67
04.11.21
4.35%
07.11.20

Known brand
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Traumtanz 
22.10.20 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€128.00
06.09.20
€125.00
04.11.21
-3.25%
06.11.20

Future proof or reliable business model
Higher risks for its business
Risky Investment
phonebroker 
06.09.20 50%
buy
PerkinElmer Inc.

Start price
Target price
Perf. (%)
€104.00
03.09.20
-
04.11.21
9.62%
05.11.20

Growths faster than the competition
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Vortex 
03.09.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€54.61
23.10.20
€55.00
31.10.20
-8.91%
31.10.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
23.10.20 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€51.42
20.10.20
€50.00
22.10.20
-1.26%
22.10.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
20.10.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€28.65
12.07.20
-
17.10.20
9.93%
17.10.20

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
tinelchen 
12.07.20 50%